This article in HemOnc Today describes a recent study that evaluated the use of specific biomarkers, namely global longitudinal strain (GLS) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) to identify childhood cancer survivors who may be at risk for cardiomyopathy. The study was done through the St. Jude Lifetime Cohort study.
Archives: News
News stories
Exercise Is A Proven, Powerful Medicine For Cancer Survivors
Sometimes, moving our bodies is the LAST thing we want to do. Cancer survivorship can be exhausting. Fatigue is one of the most common effects of cancer treatment. And, the more late effects begin to pile up, the more tired we become, and the more likely we are to succumb to the couch. But there are many, many reasons why we shouldn’t.
Even a small amount of exercise can have a significant impact. Just about everyone can benefit from a daily walk. Research has shown, time and time again, that exercise improves our bodies AND our minds.
Facing the Fear of Cancer Recurrence: A Closer Look at What Triggers It and What You Can Do About It
Almost all cancer survivors have a few things in common: shock at being diagnosed, significant challenges in dealing with the side effects of treatment, and anxiety or worry when active treatment ends and the oncologist’s office says, “We’ll see you in three months.”
Doxorubicin Exposure and Breast Cancer Risk in Survivor of Adolescent and Adult Hodgkin Lymphoma
This research paper takes a look at the risk of breast cancer from doxorubicin exposure in female survivors of Hodgkin lymphoma who are between the ages of 15-50 years of age and five years post treatment. The period of treatment was between 1975 and 2008. The study was first presented in 2021 at the ASCO Annual Meeting.
Of note is that the authors found an increased risk of breast cancer in this cohort independent of whether or not radiation was also a part of the treatment protocol. Their conclusions include this very important point- one that we will continue to advocate for with fervor.
‘Patient Is Otherwise Healthy’
Being diagnosed with cancer at any age puts many in a tailspin.
What’s Love Got to Do With It? Who needs a heart when healthcare is broken?
Dr. Stacy Wentworth is a radiation oncology specialist in Greensboro, North Carolina, and an Assistant Professor of Radiation Oncology at Wake Forest School of Medicine.
What Cancer Survivors Should Know About Survivorship Research: Expert Perspectives
When thinking about cancer research, many people think of studies focused on evaluating new or better ways to treat the cancer itself. What may not come to mind is a type of research known as “survivorship research.”
Patient Webinar: Advances in Robotic Heart Valve Surgery
During this special patient webinar, you will learn critical insights about new advances in minimally-invasive, robotic heart valve surgery. The featured speakers are Dr. Pavan Atluri, Director of Minimally Invasive and Robotic Cardiac Surgery, and Dr. Michael Ibrahim, Director of Reconstructive Valve Surgery, at Penn Medicine.
Cameras Captured James Conner Sharing Uplifting Moment With Fellow Cancer Survivors
Here is a story to make you smile. You don’t even have to be a football fan. It’s the story of James Conner, running back for the Arizona Cardinals in the National Football League. He was diagnosed with Hodgkin’s in 2015 while a Junior at the University of Pittsburgh. He had already played two years of outstanding football, winning the Atlantic Coast Conference Player of the Year in 2014, his sophomore year.
What Does it Take to Harmonize the World’s Hodgkin Lymphoma Data?
In the first episode of The HemOnc Pulse in 2024, the lead researchers of the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) consortium discuss the immense labor and fortitude it took to successfully launch the consortium, which includes a global team of diverse experts focused on the prognosis, epidemiology, treatment, survivorship, and health outcomes in patients with Hodgkin lymphoma.